Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By stimulating https://haseebqcup009640.mybjjblog.com/setmelanotide-a-promising-new-treatment-for-obesity-48595394